Rakesh Kumar Goyal MD MRCP
Pediatric Hematology/Oncology
Medical Director, RAPT Therapeutics
Join to View Full Profile
303 IRIS StreetRedwood City, CA 94062
Phone+1 412-980-6737
Fax+1 816-302-9939
Dr. Goyal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a Stem Cell Transplant and Cellular Therapy physician with expertise in hematology/oncology, cellular therapy, and immunology. Experienced in conducting industry-sponsored and cooperative group clinical trials.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Pediatric Hematology/Oncology, 1993 - 1998
University of ConnecticutResidency, Pediatrics, 1991 - 1993
Maulana Azad Medical CollegeClass of 1984
Certifications & Licensure
CA State Medical License 2020 - 2026
KS State Medical License 2015 - 2020
MO State Medical License 2015 - 2020
PA State Medical License 1998 - 2016
American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Jun 20
- Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant Start of enrollment: 2013 Mar 21
- Join now to see all
Publications & Presentations
PubMed
- 11 citationsHigh risk of relapsed disease in patients with NK/T cell chronic active Epstein-Barr virus disease outside of Asia.Blachy J. Dávila Saldaña, Tami D John, Challice L. Bonifant, David Buchbinder, Sharat Chandra
Blood Advances. 2021-10-20 - Adrenocortical Function in Children With Brain Tumors and Pediatric Hematopoietic Cell Transplantation Recipients.Koral Shah, Jennifer W Boyd, Julia R. Broussard, Kevin Ginn, Rukhsana Rahmetulla
Journal of Pediatric Hematology/oncology. 2021-05-31 - 5 citationsA multicenter report on the safety and efficacy of plerixafor based stem cell mobilization in children with malignant disorders.Nabanita Bhunia, Rolla Abu-Arja, Joseph R. Stanek, Lubna S Mehyar, Peter J. Shaw
Transfusion. 2021-01-21
Abstracts/Posters
- Preemptive Administration of Ruxolitinib Rapidly Ameliorate Gvhd after Allo-Hematopoietic Stem Cell Transplantation: A Single-Center Retrospective StudyRakesh K. Goyal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Cathelicidin Antimicrobial Peptide Expression Is Inversely Associated with Absolute Neutrophil Counts in Pediatric HCT RecipientsRakesh K. Goyal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
